$AVA

Results: Avista Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Avista Corporation reported quarterly results with revenue of $413m matching analyst expectations, but statutory profit of $0.43 per share, 84% above forecast. Analysts updated 2026 estimates to $1.97b revenue and EPS of $2.59, versus prior $1.99b and $2.61. The consensus price target stayed at $41.33 despite the stock falling 6.3% to $39.21.

Original reporting
Published Aug 5, 2026, 1:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 7:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Results: Avista Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates — source image
Decision brief

The 30-second read

$AVANeutralLow
01

Why it matters

It reports a post-results share decline, an EPS beat versus forecast, and modest consensus estimate changes with an unchanged price target.

02

Market read

Traders get a quick read on whether the quarter meaningfully changed consensus expectations; the article says it did not, with the $41.33 price target held.

03

What to watch

The article does not detail guidance, rate-case developments, or cost drivers behind the statutory EPS beat, which could matter more than the small consensus revisions.

Relevance 4/10Novelty 4/10Timing: post-quarter consensus update, reported today

Background

The article summarizes Avista’s latest quarterly results and how analysts updated their statutory forecasts for 2026.

Company-level read

Ticker impact

$AVANeutralMedium confidence
Context

Avista shares fell 6.3% after results, while analysts updated 2026 revenue to $1.97B and EPS to $2.59, keeping the $41.33 price target steady.

Expected impact

Near-term volatility may persist given the post-results drop, but the steady consensus price target suggests limited incremental upside/downside from this update alone.

Evidence & confidence

The text provides updated 2026 revenue/EPS forecasts and explicitly states analysts reconfirmed the $41.33 price target, implying limited revision to the valuation framework.

Market effects

As a utility, Avista’s steady consensus growth versus the wider industry may reinforce a “stable but not accelerating” read-through for covered peers.

No specific regional spillover is described beyond Avista’s own results and consensus changes.

No global macro or cross-border linkage is provided.

Counterpoint

The EPS beat (84% above forecast) could be interpreted as a signal of better earnings quality, so the lack of price-target change may underreact to fundamentals.

Key entities

  • Avista Corporation

    Utility company whose quarterly results and subsequent analyst forecast updates are discussed.

Related articles

$AVAMed

AVISTA CORP (AVA): Results of Operations and Financial Condition

AVISTA CORP (AVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ava-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Contact: Investors: Stacey Walters (509) 495-2046 stacey.walters@avistacorp.com Media: Lena Funston (509) 495-8090 lena.funston@avistacorp.com Avista 24/7 Media Access (509) 495-4174 Avista Corp. Reports Q2 2026 Financial Resu

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).